Biogen Inc.
BIIB
$129.44
$3.853.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.97% | -0.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.97% | -0.45% | |||
| Cost of Revenue | -0.96% | -8.64% | |||
| Gross Profit | -0.97% | 2.41% | |||
| SG&A Expenses | -15.34% | 17.65% | |||
| Depreciation & Amortization | 22.86% | -30.16% | |||
| Other Operating Expenses | 1.75% | -17.60% | |||
| Total Operating Expenses | -9.22% | -1.41% | |||
| Operating Income | 29.17% | 3.23% | |||
| Income Before Tax | 6.76% | -35.37% | |||
| Income Tax Expenses | 185.08% | -60.32% | |||
| Earnings from Continuing Operations | -9.82% | -31.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.82% | -31.35% | |||
| EBIT | 29.17% | 3.23% | |||
| EBITDA | 21.52% | 2.55% | |||
| EPS Basic | -10.07% | -31.35% | |||
| Normalized Basic EPS | 18.15% | 19.76% | |||
| EPS Diluted | -9.94% | -31.54% | |||
| Normalized Diluted EPS | 18.06% | 19.76% | |||
| Average Basic Shares Outstanding | 0.27% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.34% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||